ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : NHMRC Project Grants
Research Topic : RAS oncogenes
Clear All
Filter by Field of Research
Medical and Health Sciences (7)
Haematology (6)
Protein Targeting And Signal Transduction (5)
Oncology And Carcinogenesis (3)
Cancer Therapy (excl. Chemotherapy and Radiation Therapy) (2)
Cell Development, Proliferation and Death (2)
Biochemistry And Cell Biology Not Elsewhere Classified (1)
Cancer Cell Biology (1)
Cell Development (Incl. Cell Division And Apoptosis) (1)
Endocrinology (1)
Gene Therapy (1)
Medical and Health Sciences not elsewhere classified (1)
Molecular Targets (1)
Nutritional science (1)
Oncology and Carcinogenesis not elsewhere classified (1)
Reproduction (1)
Signal Transduction (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (53)
Filter by Status
Closed (53)
Filter by Scheme
NHMRC Project Grants (53)
Filter by Country
Search did not return any results.
Filter by Australian State/Territory
Search did not return any results.
  • Researchers (0)
  • Funded Activities (53)
  • Organisations (0)
  • Funded Activity

    Control Of The Ras/Erk Signaling Pathway By The Brahma Chromatin-remodeling Complex

    Funder
    National Health and Medical Research Council
    Funding Amount
    $524,820.00
    Summary
    Hormones bind and initiate molecular signals within cells to proliferate or change into specific cell types. This is important for growth and development of different tissues. A pathway which is critical for transmitting the effects of hormones in cells is the Ras pathway. New studies by the applicants indicate that the Brahma complex, a molecule important in controlling the levels of proteins in cells, activates the Ras pathway. This project will define how Brahma controls the Ras pathway.
    More information
    Funded Activity

    Development Of Anti-cancer Reagents That Counteract Onc Ogenic Ras Genes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $154,679.00
    More information
    Funded Activity

    An Analysis Of C-Cbl Function By Gene Targeting Of Sequences Involved In Protein Interactions

    Funder
    National Health and Medical Research Council
    Funding Amount
    $855,826.00
    More information
    Funded Activity

    Modulation Of Receptor Tyrosine Kinase Signalling By Cbl

    Funder
    National Health and Medical Research Council
    Funding Amount
    $350,037.00
    More information
    Funded Activity

    Targeting KRAS Mutations In Cancer Using A Novel SiRNA Delivery Technology

    Funder
    National Health and Medical Research Council
    Funding Amount
    $498,899.00
    Summary
    Mutations in a gene called KRAS are found in 20% of human cancers but are impossible to target with existing treatments. RNA interference is a promising new way to target genes previously considered undruggable, but there is no way to deliver the molecules required for RNA interference to tumours. We will evaluate the ability of a new nanotechnology based delivery system (antibody targeted minicells) to deliver RNA interference, thereby selectively targeting of KRAS in tumours while avoiding tox .... Mutations in a gene called KRAS are found in 20% of human cancers but are impossible to target with existing treatments. RNA interference is a promising new way to target genes previously considered undruggable, but there is no way to deliver the molecules required for RNA interference to tumours. We will evaluate the ability of a new nanotechnology based delivery system (antibody targeted minicells) to deliver RNA interference, thereby selectively targeting of KRAS in tumours while avoiding toxicity to normal tissue.
    Read more Read less
    More information
    Funded Activity

    A Genetic Analysis Of SOS And CBL In RAS Signalling

    Funder
    National Health and Medical Research Council
    Funding Amount
    $843,304.00
    More information
    Funded Activity

    Studies Of Myeloid Leukaemogenesis In The Zebrafish

    Funder
    National Health and Medical Research Council
    Funding Amount
    $171,827.00
    Summary
    This project aims to investigate the causes of white blood cell cancer, or leukaemia, at the molecular level, using a novel approach in zebrafish. Zebrafish provide a powerful experimental model for developmental genetics, largely due to the visual and technical accessibility of embryos for experimentation. We plan to introduce a fluorescent molecular tag into the white blood cells in order to directly visualise them. We will then predispose these fish to leukaemia and screen for mutants with en .... This project aims to investigate the causes of white blood cell cancer, or leukaemia, at the molecular level, using a novel approach in zebrafish. Zebrafish provide a powerful experimental model for developmental genetics, largely due to the visual and technical accessibility of embryos for experimentation. We plan to introduce a fluorescent molecular tag into the white blood cells in order to directly visualise them. We will then predispose these fish to leukaemia and screen for mutants with enhanced or suppressed leukaemia. We anticipate that the mutants will allow new genes involved in the development of leukaemia to be identified.
    Read more Read less
    More information
    Funded Activity

    Prorenin And The Prorenin Receptor In Diabetic Retinopathy: Involvement Of The Wnt Pathway And Inflammation

    Funder
    National Health and Medical Research Council
    Funding Amount
    $580,042.00
    Summary
    Diabetic retinopathy is the leading cause of blindness in people of working age. The World Health Organization predicts that by 2030 more than 300 million people will have diabetes. Given the prevalence of diabetic retinopathy and the lack of effective treatments, there is an urgent need to identify the factors that contribute to its development. This project will determine the role of components of a hormonal system, prorenin and its receptor, in diabetic retinopathy and whether they are new ta .... Diabetic retinopathy is the leading cause of blindness in people of working age. The World Health Organization predicts that by 2030 more than 300 million people will have diabetes. Given the prevalence of diabetic retinopathy and the lack of effective treatments, there is an urgent need to identify the factors that contribute to its development. This project will determine the role of components of a hormonal system, prorenin and its receptor, in diabetic retinopathy and whether they are new targets for its treatment.
    Read more Read less
    More information
    Funded Activity

    A Biological Study Of Human Ras Oncogenes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $254,190.00
    More information
    Funded Activity

    Specific Inhibition Of Leukaemia Cell Growth By Mimetic Peptides Selected In Vivo

    Funder
    National Health and Medical Research Council
    Funding Amount
    $210,137.00
    More information

    Showing 1-10 of 53 Funded Activites

    • 1
    • 2
    • 3
    • 4
    • 5
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback